Together, these data suggest that FUS promoted cytotoxicity but reduced exhaustion of CD19 CAR-T, which explains its enhanced antitumor activity in the blood cancer model. This evidence concerns the gene CD19 and hematopoietic and lymphoid system neoplasm.